Merlos M[au] - Search Results

Year	Number of Results
1988	1
1990	1
1991	5
1992	5
1993	4
1994	2
1995	3
1996	5
1997	3
1998	6
1999	2
2000	4
2001	6
2002	1
2003	5
2004	1
2005	2
2006	5
2007	5
2008	8
2009	3
2010	4
2011	5
2012	7
2013	9
2014	7
2015	4
2016	5
2017	6
2018	5
2019	11
2020	4
2021	4

1

Sigma-1 Receptor and Pain.

Merlos M, Romero L, Zamanillo D, Plata-Salamán C, Vela JM. Merlos M, et al. Handb Exp Pharmacol. 2017;244:131-161. doi: 10.1007/164_2017_9. Handb Exp Pharmacol. 2017. PMID: 28275913 Review.

2

Urinary bladder sigma-1 receptors: A new target for cystitis treatment.

González-Cano R, Artacho-Cordón A, Romero L, Tejada MA, Nieto FR, Merlos M, Cañizares FJ, Cendán CM, Fernández-Segura E, Baeyens JM. González-Cano R, et al. Among authors: merlos m. Pharmacol Res. 2020 May;155:104724. doi: 10.1016/j.phrs.2020.104724. Epub 2020 Feb 24. Pharmacol Res. 2020. PMID: 32105755 Free article.

3

Co-crystal of tramadol-celecoxib: preclinical and clinical evaluation of a novel analgesic.

Gascon N, Almansa C, Merlos M, Miguel Vela J, Encina G, Morte A, Smith K, Plata-Salamán C. Gascon N, et al. Among authors: merlos m. Expert Opin Investig Drugs. 2019 May;28(5):399-409. doi: 10.1080/13543784.2019.1612557. Epub 2019 May 3. Expert Opin Investig Drugs. 2019. PMID: 31023091 Review.

4

Antinociception by Sigma-1 Receptor Antagonists: Central and Peripheral Effects.

Romero L, Merlos M, Vela JM. Romero L, et al. Among authors: merlos m. Adv Pharmacol. 2016;75:179-215. doi: 10.1016/bs.apha.2015.11.003. Epub 2016 Jan 27. Adv Pharmacol. 2016. PMID: 26920013 Review.

5

Investigational sigma-1 receptor antagonists for the treatment of pain.

Vela JM, Merlos M, Almansa C. Vela JM, et al. Among authors: merlos m. Expert Opin Investig Drugs. 2015;24(7):883-96. doi: 10.1517/13543784.2015.1048334. Epub 2015 Jun 3. Expert Opin Investig Drugs. 2015. PMID: 26037209 Review.

6

The Sigma 2 receptor promotes and the Sigma 1 receptor inhibits mu-opioid receptor-mediated antinociception.

Sánchez-Blázquez P, Cortés-Montero E, Rodríguez-Muñoz M, Merlos M, Garzón-Niño J. Sánchez-Blázquez P, et al. Among authors: merlos m. Mol Brain. 2020 Nov 11;13(1):150. doi: 10.1186/s13041-020-00676-4. Mol Brain. 2020. PMID: 33176836 Free PMC article.

7

Sigma 1 receptor: a new therapeutic target for pain.

Zamanillo D, Romero L, Merlos M, Vela JM. Zamanillo D, et al. Among authors: merlos m. Eur J Pharmacol. 2013 Sep 15;716(1-3):78-93. doi: 10.1016/j.ejphar.2013.01.068. Epub 2013 Mar 13. Eur J Pharmacol. 2013. PMID: 23500210 Review.

8

Pharmacological Modulation of the Sigma 1 Receptor and the Treatment of Pain.

Merlos M, Burgueño J, Portillo-Salido E, Plata-Salamán CR, Vela JM. Merlos M, et al. Adv Exp Med Biol. 2017;964:85-107. doi: 10.1007/978-3-319-50174-1_8. Adv Exp Med Biol. 2017. PMID: 28315267 Review.

9

Discovery of EST73502, a Dual μ-Opioid Receptor Agonist and σ₁ Receptor Antagonist Clinical Candidate for the Treatment of Pain.

García M, Virgili M, Alonso M, Alegret C, Farran J, Fernández B, Bordas M, Pascual R, Burgueño J, Vidal-Torres A, Fernández de Henestrosa AR, Ayet E, Merlos M, Vela JM, Plata-Salamán CR, Almansa C. García M, et al. Among authors: merlos m. J Med Chem. 2020 Dec 24;63(24):15508-15526. doi: 10.1021/acs.jmedchem.0c01127. Epub 2020 Oct 16. J Med Chem. 2020. PMID: 33064947

10

Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction.

Rodríguez-Muñoz M, Sánchez-Blázquez P, Merlos M, Garzón-Niño J. Rodríguez-Muñoz M, et al. Among authors: merlos m. Oncotarget. 2016 Aug 23;7(34):55840-55862. doi: 10.18632/oncotarget.10095. Oncotarget. 2016. PMID: 27323834 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results